AI.NYSEC3ai, INC

Form 4: C3.ai Director Michael McCaffery Acquires Stock Options

Sentiment:

SEC Form 4 Filing


Director Michael McCaffery acquired stock options in C3.ai, Inc. on October 2, 2024.

Summary

  • Michael G McCaffery, a director of C3.ai, Inc., acquired stock options on October 2, 2024.
  • The options grant the right to buy 28,032 shares of Class A Common Stock at an exercise price of $22.89.
  • The options vest quarterly, starting October 2, 2024, provided McCaffery remains a director and attends board meetings.
  • If McCaffery misses a board meeting, the vesting of 5% of the shares will be suspended and may vest only after the fifth anniversary of the vesting commencement date if attendance requirements are met in subsequent periods.

Sentiment

Score: 7

Explanation: The document reflects a routine transaction of stock options, indicating a positive alignment of interests between the director and the company. It's a standard practice, suggesting stability and confidence.

Positives

  • The acquisition of stock options by a director signals confidence in the company's future performance.
  • The vesting schedule incentivizes continued service and active participation on the board.

Risks

  • The vesting schedule is contingent on McCaffery's continued service as a director and attendance at board meetings, creating a potential risk if these conditions are not met.

Future Outlook

The document does not contain explicit forward-looking statements, but the vesting schedule implies an expectation of continued service by the director.

Industry Context

Stock option grants are a common form of executive compensation in the technology industry, aligning the interests of management and shareholders.

Comparison to Industry Standards

  • Stock option grants are a typical component of compensation packages for directors in publicly traded technology companies like C3.ai.
  • Companies such as Palantir, Snowflake, and Databricks also utilize stock options to incentivize their executives and board members.
  • The vesting schedules and exercise prices are generally structured to align with long-term company performance and shareholder value creation.

Stakeholder Impact

  • The stock option grant aligns the director's interests with those of shareholders, incentivizing actions that increase shareholder value.

Key Dates

DateDescription
10/02/2024Date of the transaction and Vesting Commencement Date.
10/01/2034Expiration date of the stock options.
10/04/2024Date of signature by Attorney-in-Fact.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.